Lead Product(s) : Burdock Root Extract
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Clinical Efficacy of Burdock Root Extract in Asymptomatic Hyperuricaemia
Details : Burdock Root Extract is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Hyperuricemia.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
June 04, 2025
Lead Product(s) : Burdock Root Extract
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of Amway Uric Acid Lowering Product on Hyperuricemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
October 16, 2023
Lead Product(s) : Undisclosed
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Undisclosed
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Professional Athletic Orthopedics | St. Louis University
Deal Size : Inapplicable
Deal Type : Inapplicable
Gold Factor on Knee Joint Health and Function
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
April 26, 2022
Lead Product(s) : Undisclosed
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Professional Athletic Orthopedics | St. Louis University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Intensive Weight Loss Diet
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Oak Foundation | The Danish Rheumatism Association | Cambridge Weight Plan
Deal Size : Inapplicable
Deal Type : Inapplicable
Weight Loss for Obese Individuals With Gout
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
September 10, 2018
Lead Product(s) : Intensive Weight Loss Diet
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Oak Foundation | The Danish Rheumatism Association | Cambridge Weight Plan
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Febuxostat
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : New Jeddah Clinic Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Use of Febuxostat in Hyperuricemia Among Hemodialysis Patients
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 11, 2017
Lead Product(s) : Febuxostat
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : New Jeddah Clinic Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Chrysanthemum Flower Oil
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Kaneka Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 11, 2014
Lead Product(s) : Chrysanthemum Flower Oil
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Kaneka Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Febuxostat
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Teijin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Febuxostat for Cerebral and caRdiorenovascular Events prEvEntion stuDy
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 15, 2013
Lead Product(s) : Febuxostat
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Teijin Pharma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Plasma
Therapeutic Area : Rheumatology
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
ACP for Local Application in Ankle Arthrodesis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 27, 2010
Lead Product(s) : Plasma
Therapeutic Area : Rheumatology
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable